ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

FDA Approves Generic Capecitabine

September 20, 2013

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.

November 14, 2003

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977